118 related articles for article (PubMed ID: 9816295)
1. Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Lang S; Kato M; Oefelein MG; Miyazono K; Nemeth JA; Kozlowski JM; Lee C
Clin Cancer Res; 1996 Aug; 2(8):1255-61. PubMed ID: 9816295
[TBL] [Abstract][Full Text] [Related]
2. Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.
Williams RH; Stapleton AM; Yang G; Truong LD; Rogers E; Timme TL; Wheeler TM; Scardino PT; Thompson TC
Clin Cancer Res; 1996 Apr; 2(4):635-40. PubMed ID: 9816213
[TBL] [Abstract][Full Text] [Related]
3. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
Kim IY; Zelner DJ; Lee C
Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
[TBL] [Abstract][Full Text] [Related]
4. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
5. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
Tam BY; Philip A
J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
[TBL] [Abstract][Full Text] [Related]
9. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
10. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients.
Kim IY; Ahn HJ; Lang S; Oefelein MG; Oyasu R; Kozlowski JM; Lee C
Clin Cancer Res; 1998 Jul; 4(7):1625-30. PubMed ID: 9676836
[TBL] [Abstract][Full Text] [Related]
12. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Nakatani T; Kurosaka M
Clin Cancer Res; 2004 Sep; 10(17):5804-7. PubMed ID: 15355909
[TBL] [Abstract][Full Text] [Related]
14. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein.
Lazzereschi D; Ranieri A; Mincione G; Taccogna S; Nardi F; Colletta G
Cancer Res; 1997 May; 57(10):2071-6. PubMed ID: 9158007
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
16. Role of transforming growth factor-beta1 in prostate cancer.
Wikström P; Damber J; Bergh A
Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
[TBL] [Abstract][Full Text] [Related]
17. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
19. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
20. The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability.
Jiang X; Zeng HS; Guo Y; Zhou ZB; Tang BS; Li FK
Chin Med J (Engl); 2004 Dec; 117(12):1825-9. PubMed ID: 15603712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]